NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.
Bevers TB, Niell BL, Baker JL, Bennett DL, Bonaccio E, Camp MS, Chikarmane S, Conant EF, Eghtedari M, Flanagan MR, Hawley J, Helvie M, Hodgkiss L, Hoyt TL, Ivanovich J, Jochelson MS, Kulkarni S, Lancaster RB, Mauer C, Maxwell J, Patel BK, Pearlman M, Philpotts L, Plecha D, Plichta JK, Shakeri S, Smith ML, Streibert CL, Strigel RM, Tumyan L, Winkler NS, Wolverton DE, Bergman MA, Kumar R, Stehman K.
Bevers TB, et al. Among authors: shakeri s.
J Natl Compr Canc Netw. 2023 Sep;21(9):900-909. doi: 10.6004/jnccn.2023.0046.
J Natl Compr Canc Netw. 2023.
PMID: 37673117
The NCCN Breast Cancer Screening and Diagnosis Panel meets at least annually to review emerging data and comments from reviewers within their institutions to guide updates to existing recommendations. These NCCN Guidelines Insights summarize the panel's decision-making and …
The NCCN Breast Cancer Screening and Diagnosis Panel meets at least annually to review emerging data and comments from reviewers within thei …